title
PROPOSED GRANT AWARD
Department: Cook County Health
Grantee: Cook County Health
Grantor: EIDOS
Request: Authorization to setup new research award for EIDOS
Purpose: The purpose of this research study is for a A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial)
Grant Amount: $560,443.00
Grant Period: 10/1/2024 - 11/30/2029
Fiscal Impact: $560,443.00
Accounts: N/A.
Concurrences:
The Budget Department has received all requisite documents and determined the fiscal impact on Cook County, if any
Summary: This Extramural Commercial contract with Edios is a 5-year trial to is for a A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial) look at. The Contract amount of $560,443 is the maximum that could be earned and depends on services rendered and number of subjects enrolled in the clinical trial. We will look to start spending in October of 2024 and approximately spend 5% of the contract amount in year1 with ramp up spend in years 2-4, and ramp down spend, once the contract is near completion.
end